Increases in Incidence of Certain Foodborne Diseases Seen During 2023
By Elana Gotkine HealthDay Reporter
MONDAY, July 8, 2024 -- During 2023, there were increases in the incidences of certain foodborne disease, which may reflect changes in diagnostic practices, according to research published in the July 4 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Hazel J. Shah, M.P.H., from the CDC in Atlanta, and colleagues summarized preliminary 2023 Foodborne Diseases Active Surveillance Network (FoodNet) data, and discussed efforts to increase FoodNet representativeness.
The researchers observed increases in the incidences of domestically acquired campylobacteriosis, Shiga toxin-producing Escherichia coli infection, yersiniosis, vibriosis, and cyclosporiasis during 2023 compared with 2016 to 2018, while the incidences of listeriosis, salmonellosis, and shigellosis remained stable. The incidence and percentage of infections diagnosed by culture-independent diagnostic tests (CIDTs) reported to FoodNet continued to increase during 2023, and there was a decrease seen in the percentage of cases yielding an isolate, affecting observed incidence trends. Since CIDTs allow for diagnosis of infections that would previously have gone undetected, increasing numbers of infections may reflect changing diagnostic practices.
"Continued surveillance is needed to monitor the impact of changing diagnostic practices on disease trends and evaluate the efficacy of prevention efforts in reducing incidence," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Digestive Disease Week, May 3-6
Digestive Disease Week, the annual meeting sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for...
Gastrointestinal Disease Tied to High Physical, Financial Burden
FRIDAY, April 18, 2025 -- Gastrointestinal (GI) diseases are responsible for a considerable and growing burden of health care use and costs within the United States, according to...
Adverse Events From Semaglutide Seen in the ED Usually GI-Related
TUESDAY, April 15, 2025 -- The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.